SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Anonymous. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30:38999.
  • 2
    Engel J Jr. Approaches to localization of the epileptogenic lesion. In: EngelJJr. ed. Surgical treatment qfthe epilepsies. New York : Raven Press: 1987:7595.
  • 3
    Rasmussen T. Tailoring of cortical excisions for frontal lobe epilepsy. Can J Neurol Sci 1991:18:60610.
  • 4
    Bancaud J, Talairach J. Clinical semiology of frontal lobe seizures. In: ChauvelP, Delgado-EscuetaAV, et al., eds. New York : Raven Press: 1992:358. ( Advances in neurology , vol. 52.).
  • 5
    Williamson PD, Van Ness PC, Wiesser H, Quesney LF. Surgically remediable extratemporal syndromes. In: EngelJJr. ed. Surgical treatment of the epilepsies. New York : Raven Press: 1993:6576.
  • 6
    Rasmussen T. Surgical treatment of patients with complex partial seizures. Adv Neurol 1975;11:41549.
  • 7
    Williamson PD, Boon PA, Thadani VM, et al. Parietal lobe epilepsy: diagnostic considerations and results of surgery. Ann Neurol 1992:31:193201.
  • 8
    Gloor P. Contributions of electroencephalography and electrocorticography to the neurosurgical treatment of the epilepsies. In: PurpuraDP, PenryJK, WalterRD, eds. Neurosurgical management of the epilepsies. New York : Raven Press; 1975:59105. ( Advances in Neurology, vol 8.).
  • 9
    Wieser HG. Electroclinical features of psychomotor seizure: a stereoelectroencephalographic study of ictal symptoms and chronotopographical seizure patterns including clinical effects of intracerebral stimulation. London : Butterworth; 1983.
  • 10
    Williamson P, Spencer SS. Clinical and EEG features of complex partial seizures of extratemporal origin. Epilepsia 1986;27(suppl):4663.
  • 11
    Quesney LF, Risinger MW. Shewmon DA. Extracranial EEG evaluation. In: EngelJJr. ed. Surgical treatment of the epilepsies. New York : Raven Press: 1993:17397.
  • 12
    Penfield W, Jasper H. Epilepsy and the functional anatomy of the human brain. Boston : Little, Brown: 1954.
  • 13
    Matthews PM, Andermann F, Arnold DL. A proton magnetic resonance spectroscopy study of focal epilepsy in humans. Neurology 1990:40:9859.
  • 14
    Cascino GD, Jack CR, Jr., Parisi JE, et al. Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol 1991;30:316.
  • 15
    Cook MJ, Fish DR, Shorvon SD, Straughan K, Stevens JM. Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain 1992;115:100115.
  • 16
    Cendes F, Andermann F, Gloor P, et al. MRI volumetric measurement of amygala and hippocampus in temporal lobe epilepsy. Neurology 1993;43:71925.
  • 17
    Jackson GD, Connelly A, Duncan JS, Grunewald RA, Gadian DG. Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology 1993;43:17939.
  • 18
    Cendes F, Andermann F, Preul MC, Arnold DL. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Ann Neurol 1994:35:2116.
  • 19
    Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 1994:44:14117.
  • 20
    Ng TC, Comair YG, Xue M, et al. Temporal lobe epilepsy: pre-surgical localization with proton chemical shift imaging. Radiology 1994:193:46572.
  • 21
    Hetherington H, Kuzniecky R, Pan J, et al. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol 1995:38:396404.
  • 22
    Garcia PA, Laxer KD, van der Grond J, Hugg JW, Matson GB, Weiner MW. Proton magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy. Ann Neurol 1995:37:27981.
  • 23
    Gotman J. Seizure recognition and analysis. In: GotmanJ, IvesJR, GloorP, eds. Long-term monitoring in epilepsy Amsterdam : Elsevier; 1985:13345.
  • 24
    Gotman J, Darcey TM, Lieb JP. Commentary: computer analysis of seizure recordings. In: EngelJJr ed. Surgical treatment of the epilepsies New York : Raven Press: 1987:3619.
  • 25
    Sharbrough FW, Gotman J. Overview of new diagnostic techniques. In: EngelJJr., ed. Surgical treatment of the epilepsies 2nd ed. New York : Raven Press; 1993:1559.
  • 26
    Olivier A, Marchand E, Peters T, Tyler J. Depth electrode implantation at The Montreal Neurological Institute and Hospital. In: EngelJJr ed. Surgical treatment of the epilepsies. New York : Raven Press: 1987:595601.
  • 27
    Haase A, Frahm J. Multiple chemical-shift-selective NMR imaging using stimulated echoes. J Magn Reson 1985;64:94102.
  • 28
    Ordidge RJ, Cresshull ID. The correction of transient Bo field shifts following the application of pulse gradients by phase correction in the time domain. J Magn Reson 1986:69:1515.
  • 29
    de Beer R, Van den Boogaart A, Van Ormondt D, Pijnappel WWF. Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets. NMR Biomed 1992;5:1718.
  • 30
    van der Veen JW, de Beer R, Luyten PR, van Ormondt D. Accurate quantification of in vivo 31 P NMR signals using the variable projection method and prior knowledge. Magn Reson Med 1988;6:928.
  • 31
    Gadian DG, Connelly A, Duncan JS, et al. 1H magnetic resonance spectroscopy in the investigation of intractable epilepsy. Acta Neurol Scand Suppl 1994:152:11621.
  • 32
    Tallan HH, Moore S, Stein WH. N-acetyl-L-Aspartic acid in brain. J Biol Chem 1956:219:25764.
  • 33
    Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989;13:2331.
  • 34
    Moffett JR, Namboodiri MAA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991;2:1314.
  • 35
    Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45:3745.
  • 36
    Hugg JW, Laxer KD, Matson GB, Maudsley AA, Weiner MW. Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1993:34:78894.
  • 37
    Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson B 1993;102:919.
  • 38
    Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:21927.
  • 39
    Stanley JA, Drost DJ, Williamson PC, Thompson RT. The use of a priori knowledge to quantify short echo in vivo 1H MR spectra. Magn Reson Med 1995:34:1724.
  • 40
    Cendes F, Andermann F, Silver K, Arnold DL. Imaging of axonal damage in vivo in Rasmussen's syndrome. Brain 1995;118:7538.
  • 41
    Cendes F, Stanley JA, Dubeau F, Andermann F, Arnold DL. Proton magnetic resonance spectroscopic imaging for discrimination of absence and complex partial seizures. Ann Neurol 1997;41:7481.
  • 42
    Frahm J, Bruhm H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989;11:4763.
  • 43
    Mathews PM, Andermann F, Silver K, Karpati G, Arnold DL. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondria1 encephalomyopathies. Neurology 1993:43:248490.